GRAIL, Inc. Increase (Decrease) in Prepaid Expense
GRAIL, Inc. (GRAL) reported Increase (Decrease) in Prepaid Expense of $1.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-06
- GRAIL, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$1.04M.
- GRAIL, Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $2.12M.
- GRAIL, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was -$14.00K.
- GRAIL, Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $1.44M.
- GRAIL, Inc. increase (decrease) in prepaid expense for fiscal 2025 was -$3.36M.
- GRAIL, Inc. increase (decrease) in prepaid expense for fiscal 2024 was -$1.82M, a 300.77% decline from fiscal 2023.
- GRAIL, Inc. increase (decrease) in prepaid expense for fiscal 2023 was $908.00K, a 91.37% decline from fiscal 2023.
- GRAIL, Inc. increase (decrease) in prepaid expense for fiscal 2023 was $10.53M.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.08M 10-Q · filed 2026-08-06 | $1.06M derived: sum of 3 quarters · filed 2026-08-06 | $2.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.12M 10-Q · filed 2026-05-07 | $2.10M derived: sum of 2 quarters · filed 2026-05-07 | $3.55M derived: sum of 3 quarters · filed 2026-05-07 | $1.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.43M derived: sum of 2 quarters · filed 2026-03-12 | -$539.00K derived: sum of 3 quarters · filed 2026-08-06 | -$3.36M 10-K · filed 2026-03-12 |
| 2025-09-30 | $1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$525.00K derived: sum of 2 quarters · filed 2026-08-06 | -$3.35M 10-Q · filed 2025-11-13 | -$6.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.79M 10-Q · filed 2026-08-06 | -$7.89M derived: sum of 3 quarters · filed 2026-08-06 | -$9.14M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.82M 10-Q · filed 2026-05-07 | -$5.92M derived: sum of 2 quarters · filed 2026-05-07 | -$7.17M derived: sum of 3 quarters · filed 2026-05-07 | -$8.22M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$4.35M derived: sum of 2 quarters · filed 2026-03-12 | -$5.40M derived: sum of 3 quarters · filed 2026-03-12 | -$1.82M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.30M derived: sum of 2 quarters · filed 2025-11-13 | $1.28M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $2.53M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $3.58M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $908.00K 10-K · filed 2025-03-05 | |||
| 2023-01-01 | $10.53M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |